Aviv Gazit
30Patents
15h-index
42Co-inventors
81Inventor score
Filing activity: Apr 16, 1991 → Dec 17, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5217999A | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | Chemistry; Metallurgy | 183 | Expired |
| US5789427A | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 95 | Expired |
| US5851999A | FLK-1 is a receptor for vascular endothelial growth factor | Physics | 88 | Expired |
| US5773476A | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 85 | Expired |
| US5792771A | Quinazoline compounds and compositions thereof for the treatment of disease | Physics | 82 | Expired |
| US6331555A | Treatment of platelet derived growth factor related disorders such as cancers | Human Necessities | 81 | Expired |
| US5700823A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 76 | Expired |
| US5712395A | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis | Physics | 64 | Expired |
| US5763441A | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis | Physics | 53 | Expired |
| US5932580A | PDGF receptor kinase inhibitory compounds their preparation and compositions | Chemistry; Metallurgy | 51 | Expired |
| US5196446A | Certain indole compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 48 | Expired |
| US5990141A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 47 | Expired |
| US6126917A | Epidermal growth factor receptor binding compounds for positron emission tomography | Human Necessities | 36 | Expired |
| US5981569A | Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease | Physics | 36 | Expired |
| US5700822A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6596878B2 | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 15 | Expired |
| US5849742A | Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis | Physics | 12 | Expired |
| US5656655A | Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 12 | Expired |
| US6426366B1 | Pharmaceutical compositions comprising tyrphostins | Human Necessities | 10 | Expired |
| USRE38761E1 | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | General | 9 | Expired |
| US8604245B2 | Tri-aryl compounds and compositions comprising the same | Chemistry; Metallurgy | 6 | Active |
| US8609736B2 | Telomerase activating compounds and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US5677329A | Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase | Chemistry; Metallurgy | 4 | Expired |
| US6358954B1 | PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same | Human Necessities | 4 | Expired |
| US7217737B2 | Method and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 3 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.